Abstract
Head and neck squamous cell carcinomas have multiple genetic alterations that can influence clinical response to treatment. It is important to evaluate how distinct alterations affect response to targeted agents to identify a subset of patients who can benefit from therapy, improving survival and decreasing toxicity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3719-3721 |
| Number of pages | 3 |
| Journal | Clinical Cancer Research |
| Volume | 19 |
| Issue number | 14 |
| DOIs | |
| State | Published - Jul 15 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Dual PI3K/mTOR inhibitors: Does p53 modulate response?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS